<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Through exome resequencing, we identified two unique mutations in recombination signal binding protein for immunoglobulin kappaÂ J (RBPJ) in two independent families affected by <z:e sem="disease" ids="C0265268" disease_type="Disease or Syndrome" abbrv="AOS">Adams-Oliver syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOS</z:e>), a rare multiple-malformation disorder consisting primarily of <z:hpo ids='HP_0001057'>aplasia cutis congenita</z:hpo> of the vertex scalp and transverse terminal limb defects </plain></SENT>
<SENT sid="1" pm="."><plain>These identified mutations link RBPJ, the primary transcriptional regulator for the Notch pathway, with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AOS</z:e>, a human <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Functional assays confirmed impaired DNA binding of mutated RBPJ, placing it among other notch-pathway proteins altered in human <z:e sem="disease" ids="C0567439" disease_type="Disease or Syndrome" abbrv="">genetic syndromes</z:e> </plain></SENT>
</text></document>